logo

For the Inventor, By the Inventor

Gaithersburg, MD, United States of America

Yanto Lunardi-Iskandar

This inventor holds 13 USPTO granted patents and 1 published patent application. Top assignees: University System of Maryland, The United States of America as Represented by the Department of Health, Nobel Biosciences LLC. Active years: 1996-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yanto Lunardi-Iskandar. Retrieved from https://idiyas.com/inventor/yanto-lunardi-iskandar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 92.3

Average Co-Inventor Count = 2.9

ph-index = 9

Forward Citations = 248(Granted Patents)


Company Filing History:

goldMedal8 out of 2,029 
 
University System of Maryland
 patents
silverMedal2 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
bronzeMedal1 out of 2 
 
Nobel Biosciences LLC
 patents
4. 1 out of 2,202 
 
The United States of America as Represented by the Secretary of
 patents
5. 1 out of 834,601 
Other
 patents

Years Active: 1996-2015

Loading Chart...
13 patents (USPTO):Explore Patents
1. 9175077 - Nucleic acids encoding biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA) (2015-11-03),
2. 6805882 - Therapeutic fractions of sources of HCG (2004-10-19),
3. 6699834 - Method for treating cancer (2004-03-02),
4. 6699656 - Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin (2004-03-02),
5. 6620416 - Method for treating HIV (2003-09-16),
6. 6596688 - Method for promoting hematopoiesis (2003-07-22),
7. 6583109 - Therapeutic polypeptides from &bgr;-hCG and derivatives (2003-06-24),
8. 6319504 - Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin (2001-11-20),
9. 5997871 - Treatment and prevention of cancer by administration of derivatives of (1999-12-07),
10. 5968513 - Method of promoting hematopoiesis using derivatives of human chorionic (1999-10-19),
11. 5877148 - Treatment of cancer with human chorionic gonadotropin (1999-03-02),
12. 5677275 - Treatment of cancer with human chorionic gonadotropin (1997-10-14),
13. 5569602 - First immortalized Kaposi's sarcoma cell line (1996-10-29),

Title: Yanto Lunardi-Iskandar: Pioneering Inventor from Gaithersburg

Introduction: Yanto Lunardi-Iskandar is a distinguished inventor based in Gaithersburg, MD, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Yanto Lunardi-Iskandar holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating solutions for a better future.

Career Highlights: With a career spanning over two decades, Yanto has worked with leading tech companies, research institutions, and universities, where he has spearheaded projects that have revolutionized industries and improved people's lives.

Collaborations: Yanto Lunardi-Iskandar has collaborated with top scientists, engineers, and visionaries from around the world, fostering a culture of innovation and excellence in all his endeavors.

Conclusion: Yanto Lunardi-Iskandar's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, cements his legacy as a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…